The role of Act1, a NF-κB-activating protein, in IL-6 and IL-8 levels induced by IL-17 stimulation in SW982 cells

References

• Alonzi T, Fattori E, Lazzaro D, et al. (1998). Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187:461–8
   PubMed Web of Science ®Google Scholar
• Annunziato F, Cosmi L, Liotta F, et al. (2009). Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 5:325–31
   PubMed Web of Science ®Google Scholar
• Asahara H, Asanuma M, Ogawa N, et al. (1995). High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis. Biochem Mol Biol Int 37:827–32
   PubMedGoogle Scholar
• Baldwin AS Jr. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649–83
   PubMed Web of Science ®Google Scholar
• Chang SH, Park H, Dong C. (2006). Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 281:35603–7
   PubMed Web of Science ®Google Scholar
• Di Cesare A, Di Meglio P, Nestle FO. (2009). The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339–50
   PubMed Web of Science ®Google Scholar
• Han Z, Boyle DL, Manning AM, Firestein GS. (1998). AP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28:197–208
   PubMed Web of Science ®Google Scholar
• Handel ML, McMorrow LB, Gravallese EM. (1995). Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 38:1762–70
   PubMed Web of Science ®Google Scholar
• Honorati MC, Meliconi R, Pulsatelli L, et al. (2001). High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford) 40:522–7
   PubMed Web of Science ®Google Scholar
• Inoue A, Takahashi KA, Mazda O, et al. (2005). Electro-transfer of small interfering RNA ameliorated arthritis in rats. Biochem Biophys Res Commun 336:903–8
   PubMed Web of Science ®Google Scholar
• Katz Y, Nadiv O, Beer Y. (2001). Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: A possible role as a “fine-tuning cytokine” in inflammation processes. Arthritis Rheum 44:2176–84
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. (2009). IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517
   PubMed Web of Science ®Google Scholar
• Leonardi A, Chariot A, Claudio E, et al. (2000). CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA 97:10494–9
   PubMedGoogle Scholar
• Li X, Commane M, Nie H, et al. (2000). Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci USA 97:10489–93
   PubMedGoogle Scholar
• Lubberts E, Koenders MI, Oppers-Walgreen B, et al. (2004). Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–9
   PubMed Web of Science ®Google Scholar
• Makarov SS. (2001). NF-kappa B in rheumatoid arthritis: A pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res 3:200–6
   PubMedGoogle Scholar
• Marok R, Winyard PG, Coumbe A, et al. (1996). Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 39:583–91
   PubMed Web of Science ®Google Scholar
• May MJ, D'Acquisto F, Madge LA, et al. (2000). Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289:1550–4
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. (2009). Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888–98
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. (2003). Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–7
   PubMed Web of Science ®Google Scholar
• Novatchkova M, Leibbrandt A, Werzowa J, et al. (2003). The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 28:226–9
   PubMed Web of Science ®Google Scholar
• Pahl HL. (1999). Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 18:6853–66
   PubMed Web of Science ®Google Scholar
• Pisitkun P, Claudio E, Ren N, et al. (2010). The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody. Arthritis Rheum 62:3334–44
   PubMedGoogle Scholar
• Qian Y, Liu C, Hartupee J, et al. (2007). The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8:247–56
   PubMed Web of Science ®Google Scholar
• Qian Y, Zhao Z, Jiang Z, Li X. (2002). Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc Natl Acad Sci USA 99:9386–91
   PubMedGoogle Scholar
• Rothwarf DM, Zandi E, Natoli G, Karin M. (1998). IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395:297–300
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Xu J, Storm G, et al. (2005). Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum 52:1314–18
   PubMed Web of Science ®Google Scholar
• Xu S, Cao X. (2010). Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7:164–74
   PubMed Web of Science ®Google Scholar
• Zamore PD, Haley B. (2005). Ribo-gnome: The big world of small RNAs. Science 309:1519–24
   PubMed Web of Science ®Google Scholar
• Zandi E, Rothwarf DM, Delhase M, et al. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91:243–52
   PubMed Web of Science ®Google Scholar